These necrotic GBM cancer cells release high mobility group box 1 (HMGB1) and cyclophilin A that enhance chemoattraction and maturation of dendritic cells (DCs) as initiators of antitumor immunity (140, 141). The gene discussed is HMGB1; the disease is glioblastoma.